People In The News – Tracking The Latest Industry Personnel Moves
Executive Summary
New top leadership at BrainStorm Cell Therapeutics, Rexahn Pharmaceuticals; BioInvent seeking new CEO; Clancy steps down as AHRQ director; co-founders from Anacor Pharmaceuticals and InVivo Therapeutics recognized by White House. More personnel announcements in this month’s column.
You may also be interested in...
Spielberg’s Replacement At FDA Also Will Have Strong Industry Ties
Former J&J and Sandoz executive Leona Brenner-Gati to become acting deputy commissioner for medical products and tobacco following the departure of Stephen Spielberg.
AstraZeneca’s Executive Shakeup Includes Global Strategist To Be Named Later
AstraZeneca's new CEO Pascal Soriot signaled significant change is afoot for the troubled drug maker by eliminating the jobs of R&D President Martin Mackay and Exec VP-Global Commercial Tony Zook.
Clinton Veteran DeParle Brings Medicare, Budget Pragmatism To White House
Sebelius-DeParle team fuses elected government manager with insurance knowledge with Washington health professional with hands-on budget and Medicare/Medicaid experience.